يعرض 1 - 20 نتائج من 209 نتيجة بحث عن '"Van Den Broek, D."', وقت الاستعلام: 0.72s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المصدر: Yeghaian , M , Bodalal , Z , Tareco Bucho , T M , Kurilova , I , Blank , C U , Smit , E F , van der Heijden , M S , Nguyen-Kim , T D L , van den Broek , D , Beets-Tan , R G H & Trebeschi , S 2024 , ' Integrated noninvasive diagnostics for prediction of survival in immunotherapy ' , Immuno-Oncology and Technology , vol. 24 , 100723 . https://doi.org/10.1016/j.iotech.2024.100723

  3. 3
    Academic Journal

    المصدر: van der Leest , P , Rozendal , P , Hinrichs , J , van Noesel , CJM , Zwaenepoel , K , Deiman , B , Huijsmans , CJJ , van Eijk , R , Speel , EJM , van Haastert , RJ , Ligtenberg , MJL , van Schaik , RHN , Jansen , MPHM , Dubbink , HJ , de Leng , WW , Leers , MPG , Tamminga , M , van den Broek , D , van Kempen , LC & Schuuring , E 2024 , ' External Quality Assessment on Molecular Tumor Profiling ....

    وصف الملف: application/pdf

  4. 4
    Academic Journal

    المصدر: Jebbink , M , de Langen , A J , Monkhorst , K , Boelens , M C , van den Broek , D , van der Noort , V , de Gooijer , C J , Mahn , M , van der Wekken , A J , Hendriks , L , Hashemi , S M S , Paats , M S , Dingemans , A C & Smit , E F 2023 , ' Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC ' , JTO Clinical and Research Reports , vol. ....

  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal

    المصدر: Heitzer , E , van den Broek , D , Denis , M G , Hofman , P , Hubank , M , Mouliere , F , Paz-Ares , L , Schuuring , E , Sültmann , H , Vainer , G , Verstraaten , E , de Visser , L & Cortinovis , D 2022 , ' Recommendations for a practical implementation of circulating tumor DNA mutation testing in metastatic non-small-cell lung cancer ' , ESMO OPEN , vol. 7 , no. 2 , 100399 . https://doi.org/10.1016/j.esmoop.2022.100399

  8. 8
    Academic Journal
  9. 9
    Academic Journal

    Relation: pii: cancers14071783; Koole, S. N., Vessies, D. C. L., Schuurbiers, M. M. F., Kramer, A., Schouten, R. D., Degeling, K., Bosch, L. J. W., van den Heuvel, M. M., van Harten, W. H., van den Broek, D., Monkhorst, K. & Retel, V. P. (2022). Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. CANCERS, 14 (7), https://doi.org/10.3390/cancers14071783.; http://hdl.handle.net/11343/307259

  10. 10
  11. 11
    Conference
  12. 12
    Conference
  13. 13
    Academic Journal
  14. 14
  15. 15
    Academic Journal

    المصدر: van der Laan , P , van der Graaf , W T A , van den Broek , D , van Boven , H , Heeres , B C , Schrage , Y , Haas , R L , Steeghs , N & van Houdt , W J 2024 , ' Interleukin-6 in relation to early recurrence in primary, localized soft tissue sarcoma : An addition for existing risk classification systems? ' , European Journal of Surgical Oncology , vol. 50 , no. 9 , 108530 . https://doi.org/10.1016/j.ejso.2024.108530

  16. 16
    Academic Journal

    المصدر: van Veggel , BAMH , van der Wekken , AJ , Paats , MS , Hendriks , LEL , Hashemi , SMS , Daletzakis , A , van den Broek , D , Bosch , LJW , Monkhorst , K , Smit , EF & de Langen , AJ 2024 , ' A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer ' , Cancer , vol. 130 , no. 5 , pp. 683-691 . https://doi.org/10.1002/cncr.35090

  17. 17
    Academic Journal

    المصدر: van't Erve , I , Rovers , K P , Constantinides , A , Bolhuis , K , Wassenaar , E C E , Lurvink , R J , Huysentruyt , C J , Snaebjornsson , P , Boerma , D , van den Broek , D , Buffart , T E , Lahaye , M J , Aalbers , A G , Kok , N F , Meijer , G A , Punt , C J , Kranenburg , O , de Hingh , I H J T & Fijneman , R J A 2021 , ' Detection ....

  18. 18
    Academic Journal

    Relation: van Delft, F., Muller, M., Langerak, R., Koffijberg, H., Retel, V., van den Broek, D. & IJzerman, M. (2021). Modeling Diagnostic Strategies to Manage Toxic Adverse Events following Cancer Immunotherapy. MEDICAL DECISION MAKING, 41 (6), pp.693-705. https://doi.org/10.1177/0272989X211002756.; http://hdl.handle.net/11343/280378

  19. 19
    Academic Journal
  20. 20
    Academic Journal